Atopy, but not obesity is associated with asthma severity among children with persistent asthma

Kim D Lu1, Wanda Phipatanakul2, Matthew S Perzanowski3

  • 1a Department of Pediatrics , Division of Pediatric Pulmonary, University of California, Irvine School of Medicine , Irvine , CA , USA.

Insights

In children with persistent asthma, obesity did not worsen asthma control or severity. However, atopy, or allergic sensitization, was linked to more severe asthma symptoms and poorer lung function.

Area of Science:

  • Pediatric Allergy and Immunology
  • Respiratory Medicine
  • Public Health

Background:

  • Obesity and atopic sensitization are known risk factors for childhood asthma.
  • The comparative impact of obesity versus atopy on asthma control and severity in children remains unclear.
  • This study focuses on a population of predominantly low-income, minority children and adolescents with persistent asthma.

Purpose of the Study:

  • To investigate the association between weight status (obesity) and atopy with asthma control and severity.
  • To compare the relative influence of obesity and atopy on asthma outcomes in a specific pediatric population.
  • To inform clinical management strategies for persistent asthma in vulnerable child populations.

Main Methods:

  • Cross-sectional analysis of 832 children and adolescents (5-17 years) with persistent asthma.
  • Data collected from December 2010 to August 2014 at Johns Hopkins Hospital and Children's Hospital of Boston.
  • Assessments included clinical evaluations, asthma questionnaires, lung function tests, skin prick testing, and adiposity measures.

Main Results:

  • Obesity was not associated with worse asthma control or severity in this cohort.
  • A higher degree of atopy correlated with reduced lung function.
  • Greater atopy was also linked to higher asthma severity scores and increased medication requirements.

Conclusions:

  • Atopy appears to be a more significant risk factor for asthma severity than obesity in low-income, minority children with persistent asthma.
  • Findings suggest that managing atopic sensitization may be crucial for improving asthma outcomes in this population.
  • Further research is warranted to explore the complex interplay between obesity, atopy, and asthma in diverse pediatric groups.
Abstract

Related Concept Videos

Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.8K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.7K
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.7K
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
3.6K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.3K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
2.3K